M.D.C. Holdings, Inc. (NYSE:MDC) CEO Larry A. Mizel sold 110,224 shares of the business’s stock in a transaction dated Wednesday, July 29th. The shares were sold at an average price of $44.82, for a total transaction of $4,940,239.68. Following the completion of the transaction, the chief executive officer now directly owns 230,849 shares of the company’s stock, valued at approximately $10,346,652.18. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink.

NYSE MDC opened at $45.69 on Friday. The stock has a market cap of $2.88 billion, a PE ratio of 11.13, a P/E/G ratio of 8.28 and a beta of 1.54. M.D.C. Holdings, Inc. has a fifty-two week low of $15.75 and a fifty-two week high of $48.99. The business has a 50 day moving average price of $36.51 and a two-hundred day moving average price of $34.37. The company has a quick ratio of 1.85, a current ratio of 7.53 and a debt-to-equity ratio of 0.63.

M.D.C. (NYSE:MDC) last released its earnings results on Tuesday, July 28th. The construction company reported $1.31 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.83 by $0.48. The company had revenue of $886.80 million during the quarter, compared to analysts’ expectations of $806.74 million. M.D.C. had a return on equity of 14.75% and a net margin of 7.52%. The business’s revenue was up 21.0% on a year-over-year basis. During the same period in the prior year, the business posted $0.86 EPS. Sell-side analysts anticipate that M.D.C. Holdings, Inc. will post 2.98 EPS for the current fiscal year.

The business also recently announced a quarterly dividend, which will be paid on Wednesday, August 26th. Shareholders of record on Wednesday, August 12th will be given a $0.33 dividend. This represents a $1.32 annualized dividend and a yield of 2.89%. The ex-dividend date is Tuesday, August 11th. M.D.C.’s dividend payout ratio is presently 35.48%.

Hedge funds and other institutional investors have recently modified their holdings of the business. Harel Insurance Investments & Financial Services Ltd. acquired a new stake in M.D.C. in the second quarter worth $27,000. Mutual of America Capital Management LLC increased its position in M.D.C. by 20.3% in the first quarter. Mutual of America Capital Management LLC now owns 2,145 shares of the construction company’s stock worth $50,000 after buying an additional 362 shares during the period. Benjamin F. Edwards & Company Inc. increased its position in M.D.C. by 29.4% in the first quarter. Benjamin F. Edwards & Company Inc. now owns 2,515 shares of the construction company’s stock worth $58,000 after buying an additional 572 shares during the period. Ladenburg Thalmann Financial Services Inc. increased its position in M.D.C. by 120.0% in the fourth quarter. Ladenburg Thalmann Financial Services Inc. now owns 3,106 shares of the construction company’s stock worth $120,000 after buying an additional 1,694 shares during the period. Finally, Zurcher Kantonalbank Zurich Cantonalbank increased its position in M.D.C. by 35.9% in the first quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 3,930 shares of the construction company’s stock worth $91,000 after buying an additional 1,038 shares during the period. 75.71% of the stock is currently owned by hedge funds and other institutional investors.

MDC has been the subject of several analyst reports. Evercore ISI raised shares of M.D.C. from an “in-line” rating to an “outperform” rating and set a $61.00 target price for the company in a research note on Wednesday. Wedbush dropped their price objective on shares of M.D.C. from $40.00 to $29.00 and set a “neutral” rating for the company in a research note on Thursday, April 2nd. ValuEngine downgraded shares of M.D.C. from a “sell” rating to a “strong sell” rating in a research report on Wednesday. Zacks Investment Research raised shares of M.D.C. from a “sell” rating to a “strong-buy” rating and set a $43.00 target price for the company in a research report on Tuesday, July 14th. Finally, Raymond James dropped their target price on shares of M.D.C. from $52.00 to $35.00 and set a “strong-buy” rating for the company in a research report on Thursday, April 9th. Two investment analysts have rated the stock with a sell rating, four have issued a hold rating, two have issued a buy rating and two have given a strong buy rating to the stock. The company presently has an average rating of “Hold” and an average target price of $43.33.

About M.D.C.

M.DC Holdings, Inc, through its subsidiaries, engages in the homebuilding and financial service businesses. Its homebuilding operations include purchasing finished lots or developing lots for the construction and sale primarily of single-family detached homes to first-time and first-time move-up homebuyers under the Richmond American Homes name.

Recommended Story: SEC Filing

Insider Buying and Selling by Quarter for M.D.C. (NYSE:MDC)

Receive News & Ratings for M.D.C. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for M.D.C. and related companies with MarketBeat.com's FREE daily email newsletter.